PDCD1 and breast carcinoma: There is evidence that estrogens can modulate PD-1/PD-L1 expression in endometrial tissue (191) and on immune cells (192, 193), and PD-L1 expression on HR+ breast cancer cells in vitro (194), which may limit the function of T cells in HR+ breast cancer.